Coya Therapeutics, Inc. Common Stock (COYA) stock news · rev $7.9M
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
This COYA news page leads with what Coya Therapeutics, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for COYA yet. We will not pad this page with generic market recap.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the COYA stock page; for the tape open the quote page.
COYA stock news FAQ
What are COYA's latest revenue and net income?
Latest cached Coya Therapeutics, Inc. Common Stock (COYA) revenue for Dec 31, 2025 was $7.9M. Net income was -$21.2M. Statements: https://lician.com/financials/coya
How did COYA revenue change from the prior cached period?
Cached Coya Therapeutics, Inc. Common Stock (COYA) revenue was up 123.6% from $3.6M (Dec 31, 2024) to $7.9M (Dec 31, 2025). Statements: https://lician.com/financials/coya
What is COYA's market cap?
Coya Therapeutics, Inc. Common Stock (COYA) market cap is $118.0M on the latest cached fundamentals snapshot.
What kind of company is COYA?
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Where is COYA stock news listed?
Cached stock news for Coya Therapeutics, Inc. Common Stock (COYA) is listed at https://lician.com/news/coya. Filings: https://lician.com/sec/coya
Not investment advice.